Abstract
A quantitative genetic risk assessment has been recognized as one of the goals of the research of environmental mutagens. To establish the genetic risk assessment as a practice routinely applicable to daily tasks, a collaborative study was carried out from 1996 to 1999 in the Mammalian Mutagenesis Study Group. Mitomycin C was selected as a model compound and its genetic risk was quantitatively assessed for autosomal dominant and X linked genetic diseases. In this paper, outcomes of the study are presented together with the recent progress in a genetic risk assessment on radiation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
